Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1968-12-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-2685
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
411-7
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:5684465-6-Mercaptopurine,
pubmed-meshheading:5684465-Adult,
pubmed-meshheading:5684465-Aged,
pubmed-meshheading:5684465-Humans,
pubmed-meshheading:5684465-Leukemia,
pubmed-meshheading:5684465-Middle Aged,
pubmed-meshheading:5684465-Primary Myelofibrosis,
pubmed-meshheading:5684465-Vincristine
|
pubmed:year |
1968
|
pubmed:articleTitle |
Experiences with cytogran therapy in patients with acute leukemia resistant to mercaptopurine.
|
pubmed:publicationType |
Journal Article
|